Patient Leaflet Updated 26-Sep-2024 | PAION UK Ltd
Byfavo 20 mg powder for solution for injection
Byfavo 20 mg powder for solution for injection
remimazolam
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effect you may get. See the end of section 4 for how to report side effects.
1. What Byfavo is and what it is used for
2. What you need to know before you are given Byfavo
3. How Byfavo is given
4. Possible side effects
5. How Byfavo is stored
6. Contents of the pack and other information
Byfavo is a medicine that contains the active substance remimazolam.
Remimazolam is one of a group of substances known as benzodiazepines.
Byfavo is a sedative given before a medical test or procedure to make you feel relaxed and sleepy (sedated).
Talk to your doctor or nurse before using Byfavo if you have any severe illness or condition and in particular if:
Byfavo can cause temporary loss of memory. Your doctor will assess you before you leave the hospital or clinic and give you necessary advice.
Byfavo should not be given to patients under the age of 18 years because it has not been tested in children and adolescents.
Tell your doctor if you are taking, have recently taken or might take any other medicines, in particular about:
It is important to tell your doctor or nurse if you are taking other medicines, as using more than one at the same time can change the effect of the medicines involved.
Alcohol can change the effect of Byfavo. Tell your doctor or nurse:
Do not drink alcohol for 24 hours before you are given Byfavo.
You should not use Byfavo if you are pregnant or think you may be pregnant. Tell your doctor or nurse if you are pregnant or think you may be pregnant.
If you are a breastfeeding mother, do not breastfeed for 24 hours after you are given this medicine.
Byfavo makes you sleepy, forgetful and affects your ability to concentrate. Even though these effects wear off rapidly, you must not drive and operate machinery until these effects are completely gone. Ask your doctor about when you can drive or operate machinery again.
This medicine contains 79.13 mg of dextran 40 for injection in each vial. Rarely, dextrans can cause severe allergic reactions. If you have breathing difficulty or swelling or you feel faint, get medical help at once.
Your doctor will decide on the right dose for you.
Your breathing, heart rate and blood pressure will be monitored during the procedure and the doctor will adjust the dose if needed.
A doctor or nurse will give you Byfavo by injection into your vein (blood stream) before and during your medical test or procedure. Byfavo is mixed with sterile saline to make a solution before it is used.
Your doctor or nurse will check on you for a while after sedation to make sure that you feel well and are fit to go home.
If you are given too much Byfavo, you may have the following symptoms:
Your doctor will know how to treat you.
Ask your doctor or nurse if you have any questions about the use of this medicine.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common (may affect more than 1 in 10 users)
Common (may affect up to 1 in 10 users)
Uncommon (may affect up to 1 in 100 users)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Professionals in the hospital or clinic are responsible for storing this medicine.
Keep this medicine out of the sigth and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and vial label. The expiry date refers to the last day of that month.
Chemical and physical in-use stability has been demonstrated for 24 h at 20 - 25°C.
From a microbiological point of view, unless the method of opening/reconstitution/dilution precludes the risk of microbial contamination, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user (see SmPC section 6.3).
Do not use this medicine if you notice visible particulate matter or discolouration.
See section 2, “Byfavo contains dextran 40 for injection”.
Byfavo is a white to off-white powder for solution for injection.
Pack sizes
10 vial pack
This leaflet was last revised in 08/2024.
Unit 302, Parkshot House, 5 Kew Road, Richmond, London, TW9 2PR, UK
+800 4453 4453
01932 824 100
www.paion.com
+44 2045669480